Intas Pharmaceuticals Limited — Calcium Exporter Profile
Indian Pharmaceutical Exporter · #1 for Calcium · $2.9M export value · DGFT Verified
Intas Pharmaceuticals Limited is the #1 Indian exporter of Calcium with $2.9M in export value and 57 verified shipments. Intas Pharmaceuticals Limited holds a 0.4% market share in Calcium exports across 9 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.
Intas Pharmaceuticals Limited — Calcium Export Profile: Buyers & Destinations
Where Does Intas Pharmaceuticals Limited Export Calcium?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $716.2K | 31 | 82.2% |
| ZIMBABWE | $75.1K | 15 | 8.6% |
| UGANDA | $29.3K | 10 | 3.4% |
| CONGO | $28.0K | 1 | 3.2% |
| MAURITIUS | $13.9K | 1 | 1.6% |
| MYANMAR | $3.8K | 3 | 0.4% |
| TANZANIA | $3.3K | 1 | 0.4% |
| TRINIDAD & TOBAGO | $903 | 1 | 0.1% |
| JAMAICA | $257 | 1 | 0.0% |
Intas Pharmaceuticals Limited exports Calcium to 9 countries. The largest destination is CANADA accounting for 82.2% of Intas Pharmaceuticals Limited's Calcium shipments, followed by ZIMBABWE (8.6%) and UGANDA (3.4%). These destinations reflect Intas Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Calcium from Intas Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ACCORD HEALTHCARE INC., | CANADA | $312.2K | 7 |
| BIOMEDPHARMA | CANADA | $200.0K | 4 |
| ACCORD HEALTHCARE INC | CANADA | $124.9K | 8 |
| ACCORD HEALTHCARE INC. | CANADA | $79.1K | 12 |
| PHARMACEUTICAL AND CHEMICAL | ZIMBABWE | $40.5K | 7 |
| TO THE ORDER., | ZIMBABWE | $34.7K | 8 |
| UNION DE QUERIR | CONGO | $28.0K | 1 |
| TO THE ORDER | TANZANIA | $27.2K | 5 |
| TO THE ORDER OF | UGANDA | $19.3K | 7 |
| ECO ASIA COMPANY LIMITED | MYANMAR | $3.8K | 3 |
Intas Pharmaceuticals Limited supplies Calcium to 12 buyers globally. The largest buyer is ACCORD HEALTHCARE INC., (CANADA), followed by BIOMEDPHARMA (CANADA) and ACCORD HEALTHCARE INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Calcium Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?
India exported $222.8M worth of Calcium through 15,000 shipments from 996 suppliers to 184 countries, serving 2,554 buyers globally. Intas Pharmaceuticals Limited contributes $2.9M to this total, accounting for 0.4% of India's Calcium exports. Intas Pharmaceuticals Limited ships Calcium to 9 countries through 12 buyers.
What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Calcium Exports?
Intas Pharmaceuticals Limited's average Calcium shipment value is $50.0K per consignment, based on 57 shipments totaling $2.9M. The largest destination is CANADA (82.2% of Intas Pharmaceuticals Limited's Calcium exports).
How Does Intas Pharmaceuticals Limited Compare to Other Indian Calcium Exporters?
Intas Pharmaceuticals Limited ranks #1 among 996 Indian Calcium exporters with a 0.4% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($57.0M), BIOCON PHARMA LIMITED ($43.3M), GRAVITI PHARMACEUTICALS PRIVATE LIMITED ($25.0M). Intas Pharmaceuticals Limited processed 57 shipments to 9 destination countries.
What Calcium Formulations Does Intas Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PH.DRU.& MED.: BIO ATORVASTATIN 40MG TABLETS (ATORVASTATIN CALCIUM TABLETS 40MG)[1X500T PER PACK] | $100.0K | 2 |
| PHARMA DRUGS AND MEDICINE-ACH - ATORVASTATIN 10MG 90T(ACC- CANADA EACH FILM COATED TABLET ATORVASTATIN CALCIUM USP:QTY-2NOS | $52.0K | 6 |
| PH.DRU.& MED.: ACH-ATORVASTATIN 80MG TABLETS ATORVASTATIN CALCIUM TABLETS 80MG[1X90T PER PACK] | $50.0K | 1 |
| PH.DRU.& MED.: BIO ATORVASTATIN 80MG TABLETS (ATORVASTATIN CALCIUM TABLETS 80MG)[1X100T PER PACK] | $50.0K | 1 |
| PH.DRU.& MED.: ACH-ATORVASTATIN 40MG TABLETS (ATORVASTATIN CALCIUM TABLETS 40MG)[1X90T PER PACK] | $50.0K | 1 |
| PH.DRU.& MED.: BIO ATORVASTATIN 10MG TABLETS (ATORVASTATIN CALCIUM TABLETS 10MG)[1X500T PER PACK] | $50.0K | 1 |
| PH.DRU.& MED.: ACH-ATORVASTATIN 40MG TABLETS (ATORVASTATIN CALCIUM TABLETS 40MG)[1X500T PER PACK] | $50.0K | 1 |
| PH.DRU.& MED.: ACH-ATORVASTATIN 20MG TABLETS (ATORVASTATIN CALCIUM TABLETS 20MG)[8315X1X500T] | $50.0K | 1 |
| PH.DRU.& MED.: ACH-ATORVASTATIN 10MG TABLETS (ATORVASTATIN CALCIUM TABLETS 10MG)[2016X1X90T] | $50.0K | 1 |
| PH.DRU.& MED.: ACH-ATORVASTATIN 40MG TABLETS (ATORVASTATIN CALCIUM TABLETS 40MG)[2122X1X500T] | $50.0K | 1 |
Intas Pharmaceuticals Limited exports 45 distinct Calcium formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PH.DRU.& MED.: BIO ATORVASTATIN 40MG TABLETS (ATORVASTATIN C with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Calcium to Key Markets
What Intas Pharmaceuticals Limited must comply with to export Calcium to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Intas Pharmaceuticals Limited Compare to Nearest Calcium Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | UMEDICA LABORATORIES PRIVATE LIMITED | $7.3M | 146 | 5 | $50.0K |
| 14 | HETERO LABS LIMITED | $5.1M | 131 | 9 | $38.6K |
| 1 | INTAS PHARMACEUTICALS LIMITED ★ | $2.9M | 57 | 9 | $50.0K |
| 13 | SUVEN PHARMACEUTICALS LIMITED | $1.8M | 36 | 1 | $50.0K |
| 15 | PANACEA BIOTEC PHARMA LIMITED | $1.3M | 26 | 1 | $50.0K |
Intas Pharmaceuticals Limited ranks #1 among 996 Indian Calcium exporters. Average shipment value of $50.0K compared to the market average of $223.7K. The closest competitors by value are UMEDICA LABORATORIES PRIVATE LIMITED and HETERO LABS LIMITED.
Which Indian Ports Ship Calcium Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,737 | 11.6% |
| NHAVA SHEVA SEA (INNSA1) | 1,272 | 8.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 991 | 6.6% |
| JNPT/ NHAVA SHEVA SEA | 865 | 5.8% |
| DELHI AIR | 787 | 5.2% |
| HYDERABAD ICD | 640 | 4.3% |
| DELHI AIR CARGO ACC (INDEL4) | 559 | 3.7% |
| JNPT | 542 | 3.6% |
Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Calcium Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)
Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.
Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.
About Intas Pharmaceuticals Limited
Intas Pharmaceuticals Limited exports 75 products worth $372.3M. Beyond Calcium, top products include Ras, Mycophenolate, Tacrolimus, Apixaban, Ezetimibe. View the complete Intas Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Calcium — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Calcium shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 64 individual customs records matching Intas Pharmaceuticals Limited exporting Calcium, covering 45 formulations to 9 countries via 12 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 184+ countries, 2,554+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Calcium Export Data from Intas Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Intas Pharmaceuticals Limited's Calcium exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Intas Pharmaceuticals Limited
Full Company Profile →
75 products · $372.3M total trade · 19 categories
Calcium Stats
Company Overview
Top Products by Intas Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Intas Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Calcium. For current shipment-level data, contact TransData Nexus.